ELI LILLY AND COMPANY Extinguishment of Debt, Amount
ELI LILLY AND COMPANY (LLY) reported Extinguishment of Debt, Amount of $1.65 billion for the 9-month period ending 2015-09-30, per its 10-Q filed 2016-10-28.
Discontinued › Notes › Debt
us-gaap:ExtinguishmentOfDebtAmount · last filed 2018-02-20
- ELI LILLY AND COMPANY extinguishment of debt, amount for the quarter ending 2015-09-30 was $0.00.
- ELI LILLY AND COMPANY extinguishment of debt, amount for the quarter ending 2015-06-30 was $1.65B.
| Period end | Extinguishment of Debt, Amount 3 month | Extinguishment of Debt, Amount 6 month | Extinguishment of Debt, Amount 9 month |
|---|---|---|---|
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $1.65B derived: sum of 2 quarters · filed 2018-02-20 | $1.65B 10-Q · filed 2016-10-28 |
| 2015-06-30 | $1.65B 10-K · filed 2018-02-20 | $1.65B 10-Q · filed 2016-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |